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Abstract
Background: The SCN5A encoded sodium current (INa) generates the action potential (AP) upstroke and is a major
determinantof APcharacteristics andAPpropagation incardiacmyocytes. Unfortunately, incardiacmyocytes,investigation of
kinetic properties of INa with near-physiological ion concentrations and temperature is technically challenging due to the large
amplitude and rapidly activating nature of INa, which may seriously hamper the quality of voltage control over the membrane.
We hypothesized that the alternating voltage clamp-current clamp (VC/CC) technique might provide an alternative to
traditional voltage clamp (VC) technique for the determination of INa properties under physiological conditions.
Principal Findings: We studied INa under close-to-physiological conditions by VC technique in SCN5A cDNA-transfected HEK
cells or by alternating VC/CC technique in both SCN5A cDNA-transfected HEK cells and rabbit left ventricular myocytes. In
these experiments, peak INa during a depolarizing VC step or maximal upstroke velocity, dV/dtmax, during VC/CC served as
an indicator of available INa. In HEK cells, biophysical properties of INa, including current density, voltage dependent
(in)activation, development of inactivation, and recovery from inactivation, were highly similar in VC and VC/CC
experiments. As an application of the VC/CC technique we studied INa in left ventricular myocytes isolated from control or
failing rabbit hearts.
Conclusions: Our results demonstrate that the alternating VC/CC technique is a valuable experimental tool for INa
measurements under close-to-physiological conditions in cardiac myocytes.
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Introduction
Voltage-gated Na
+ channels are responsible for the rapid action
potential upstroke of cardiac myocytes and play a vital role in the
proper conduction of the cardiac electrical impulse. Consequently,
decreased Na
+ channel function during common pathological
conditions [1–3], or as a result of administration of antiepileptic
and local anesthetic drugs [4,5] may cause conduction distur-
bances and potentially life-threatening arrhythmias. In addition,
loss-of-function mutations in the SCN5A gene encoding the pore-
forming a-subunit of the cardiac sodium channel (Nav1.5) have
been shown to underlie multiple inherited arrhythmia syndromes,
including Brugada syndrome, cardiac conduction disease, sinus
node dysfunction, sudden infant death syndrome, and atrial
standstill, while SCN5A mutations resulting in a persistent or
‘‘late’’ sodium current have been associated with long-QT
syndrome type 3 (for review, see Refs. [6,7]). Cardiac sodium
channel function is modulated by a large number of interacting
and regulatory proteins, including the auxiliary b-subunits (b1–4),
ankyrins, fibroblast growth factor homologous factor 1B, calmod-
ulin, caveolin-3, 14-3-3g, Nedd4-like ubiquitin-protein ligases,
and syntrophins (for review, see Ref. [8]). Consequently, mutations
leading to malfunctions of such proteins contribute to various
cardiac syndromes [6,8].
To understand the functional consequences of Na
+ channel
mutations or the effects of altered Na
+ channel modulation under
various pathophysiological conditions and during administration of
various drugs, biophysical properties of the Na
+ current (INa)a r e
usually studied in the whole-cell configuration of the patch clamp
technique [9] in heterologous expression systems or freshly isolated
cardiac myocytes. However, investigation of Na
+ channel kinetics
with near-physiological ion concentrations and temperature is
technically challenging due to the large amplitude and rapidly
activating nature of INa, which may seriously hamper the quality
of voltage control over the membrane [10]. In heterologous
expression systems, accurate determination of Na
+ channel proper-
ties under close-to-physiological conditions is possible by using low-
resistance patch-pipettes, adequate series resistance compensation,
and by selecting small cells with low ion channel protein expression
levels [11–17]. However, in freshly isolated cardiac myocytes, the
large INa is routinely investigated under far-from-physiological
conditions (e.g. low temperature and low extracellular Na
+
concentration) [18,19] in order to obtain reliable voltage control
during recordings. It is obvious that such experimental conditions do
PLoS ONE | www.plosone.org 1 December 2010 | Volume 5 | Issue 12 | e15772not only result in underestimation of the magnitude of the current,
but may also alter its biophysical properties [20]. In addition,
gating changes of Na
+ channel mutations may be more promi-
nent at near-physiological temperature than at room temperature
[11,14,15,21,22–24]. Furthermore, the effects of antiarrhythmic
drugs on Na
+ channels are markedly altered by temperature [25].
These findings indicate that one should be cautious extrapolating
conclusions derived from Na
+ channel data at low temperatures to
clinical situations. Finally, there is evidence that behaviour of Na
+
channel in cell expression systems may be different from that in
myocytes [26], and the increasing amount of mouse models of
various cardiac disorders [27] further advertise the need for accurate
measurements of INa and its kinetics under close-to-physiological
conditions in cardiac myocytes.
Tillnow, only few attempts have been made to record cardiac INa
under close-to-physiological conditions. Murray et al. [28] recorded
quasi-macroscopic INa in cell-attached mode using electrodes with
relatively large tip openings to record from macropatches on the
surface membrane of intact guinea pig ventricular myocytes. They
found that temperature clearly affected the voltage dependence of
INa (in)activation, resulting in a more positive membrane potential
for the half maximal (in)activation) at higher temperatures [28]. In
addition, this macropatch technique was used to characterize the
effects of heart failure on brain-type Na
+ channels in rabbit
ventricular myocytes [29]. A disadvantage of the quasi-macroscopic
INa measurements, however, is the inability to measure cellular
resting potential at the time the voltage clamp data is collected [28],
which is especially important in case of relative large quasi-
macroscopic INa which may depolarize the intact myocytes [30].
In contrast to whole-cell and macropatch INa measurements in
voltage clamp experiments, it is fairly easy to record action
potentials under close-to-physiological conditions from cardiac
myocytes in the current clamp configuration of the patch clamp
technique. The upstroke of the action potential is caused by the
flow of ions through channels specific for Na
+ [31]. Expressed in
terms of a simple resistance and capacitance circuit, the change in
membrane potential, dV/dt, is proportional to ionic current flow
and the steepest portion of the action potential upstroke, dV/
dtmax, occurs at maximal Na
+ ion flow [32]. Albeit dV/dtmax
represents the physiological, functional availability of INa, the use
of dV/dtmax as an adequate measure of Na
+ channel conductance
has been debated, with arguments, either in favour or against,
largely based on computer simulation studies (see [33–38], and
primary references cited therein). It has been concluded by both
Hondeghem [35] and Cohen et al. [34] that a future direct
comparison between INa and dV/dtmax at physiological temper-
ature and ion concentrations would be very valuable.
In the present study, we evaluated the biophysical properties of
INa expressed in human embryonic kidney (HEK) cells under
close-to-physiological conditions with the use of alternating voltage
clamp/current clamp (VC/CC) and compared the VC/CC data
to data from conventional voltage clamp (VC) experiments in
HEK cells, thus validating the use of dV/dtmax as an adequate
measure of INa. As an application of dV/dtmax as a simple tool in
studying INa characteristics under close-to-physiological condi-
tions, we used the VC/CC to characterize INa in freshly isolated
cardiac myocytes of control and heart failure rabbits.
Methods
Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Committee on the Ethics of Animal
Experiments of the Academic Medical Center of the University of
Amsterdam (Permit Number: DCA-101772) and all efforts were
made to minimize animal suffering.
Cell preparations
HEK cells. Wild-type sodium channel a-subunit construct
(0.5 mg) was transfected into QBI-HEK-293A cells (Qbiogene,
Heidelberg, Germany) together with b1-subunit construct (0.5 mg)
using lipofectamine (Gibco BRL, Life Technologies). Transfected
HEK cells were cultured in MEM (Earle’s salts and L-glutamine)
supplemented with nonessential amino acid solution, 10% FBS,
100 IU/mL penicillin, and 100 mg/mL streptomycin in a 5% CO2
incubatorat37uCfor2days.Transfectedcellswereidentified under
epifluorescent microscopy using green fluorescence protein (GFP)
as a reporter gene. To optimize the conventional voltage clamp
measurements, we selected small HEK cells (7.760.5 pF (mean6
SEM; n=45)), which tend to exhibit smaller currents and smaller
capacitative transients [17].
Rabbit ventricular myocytes. Heart failure (HF) was
induced in 4-month-old male New-Zealand White rabbits by
combined volume and pressure overload in two sequential surgical
procedures as described previously [39]. In short, volume overload
was produced by rupture of the aortic valve until pulse pressure
was increased by about 100%. Three weeks later, pressure
overload was created by suprarenal abdominal aorta constriction
of approximately 50%. Hearts were excised 3 months after the
second operation. At the time of sacrifice, a HF index based on
relative heart weight (i.e. heart weight to body weight ratio),
relative lung weight (i.e. lung weight to body weight ratio), left
ventricular end-diastolic pressure, and ascites was calculated [39].
We performed experiments if at least three of the above
parameters were abnormal [40], indicating severe HF. Previous
studies from our laboratory demonstrated that HF parameters [39]
and important cellular parameters for hypertrophy and ionic
remodeling [41] between sham-operated and age-matched non-
operated rabbits were similar. Therefore, non-operated age-
matched healthy animals served as control. To reduce
differences in Na
+ channel expression [42], midmyocardial cells
were isolated by enzymatic dissociation from the apical part of the
left ventricular free wall as described previously [43]. Single rod-
shaped myocytes exhibiting smooth surfaces and clear cross-
striations were selected for measurements.
Small aliquots of cell suspension were put in a recording
chamber on the stage of an inverted microscope. Cells were
allowed to adhere for 5 min after which superfusion with solution
at 3660.2uC was started. The extracellular solution for HEK cell
experiments contained (in mmol/L): NaCl 140, CsCl 10, CaCl2
1.8, MgCl2 1.0, glucose 5.5, HEPES 5.0, pH 7.4 (NaOH). For
myocyte measurements, the CsCl of the extracellular solution was
replaced by 5.4 mmol/L KCl.
Electrophysiology
Data acquisition. INa and AP upstrokes were measured in the
whole-cell configuration of the patch-clamp technique using an
Axopatch 200B amplifier (Molecular Devices Corporation,
Sunnyvale, CA, USA) or a custom-made amplifier, capable of fast
switching between voltage clamp (VC) and current clamp (CC)
modes. Voltage control, data acquisition, and analysis were
accomplished using custom software. Signals were low-pass
filtered with a cut-off frequency of 5 kHz and digitized at 20 kHz.
Series resistance was compensated by $80%, and potentials were
correctedforthe estimatedliquidjunctionpotential.Thetechnically
challengingINameasurements at physiologicaltemperatureinHEK
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described previously in detail [11,13]. Cell membrane capacitance
was determined as described previously [44]. For HEK cell
measurements patch pipettes (borosilicate glass; resistance
<2.0 MV) contained (mmol/L): CsCl 10, CsF 110, NaF 10,
EGTA 11, CaCl2 1.0, MgCl2 1.0, Na2ATP 2.0, HEPES 10, pH 7.2
(CsOH). For cardiac myocyte measurements patch pipettes
contained (mmol/L): K-gluc 125, KCl 20, NaCl 5, K2-ATP 5,
BAPTA 10, HEPES 10; pH 7.2 (KOH).
Conventional VC and alternating VC/CC experi-
ments. The current density, voltage dependence of Na
+ con-
ductance activation, steady-state inactivation, recovery from
inactivation, and development of slow inactivation were deter-
mined using the voltage protocols depicted in the figures and
explained in the Results. The holding potential was 2140 mV,
except in the protocols for recovery from inactivation and slow
inactivation because recovery from inactivation is voltage
dependent [19,33]. In the latter experiments we have chosen a
holding potential of 285 mV, a value close to the resting
membrane potential of working myocytes.
In alternating VC/CC experiments, cells were clamped with
protocols similar to those used in conventional VC experiments.
However, after the preconditioning voltage dV/dt was measured
by switching to the CC mode of the patch clamp amplifier.
Noteworthy, both HEK cells and freshly isolated myocytes
display fast depolarizations (in the present study named AP
upstrokes) upon switching from VC to CC mode. AP upstrokes
were elicited by 1.26 threshold (determined at 2140 mV)
current pulses through the patch pipette. Maximal upstroke
velocity (dV/dtmax) during VC/CC, offline corrected for the
contribution of stimulus current, served as an indicator of
available INa.
Figure 1. Activation of INa in HEK cells assessed with square-step voltage protocols in conventional VC experiments. a, Top: Typical
examples of Na
+ current in response to depolarizing voltage steps from 2140 mV. Bottom: Average fast and slow time constants of Na
+ current
inactivation. Note logarithmic ordinate scale. b, Average current-voltage relationship. c, Average steady-state activation. The solid line is the
Boltzmann fit to the average data. d, Typical membrane depolarizations in response to a super- and subthreshold current pulse in a HEK cell during
an alternating VC/CC experiment from a holding potential of 2140 mV (top) and the first derivatives of the resulting membrane potential changes
(dV/dt; bottom).
doi:10.1371/journal.pone.0015772.g001
Action Potential Upstroke and Sodium Current
PLoS ONE | www.plosone.org 3 December 2010 | Volume 5 | Issue 12 | e15772To determinethe activation characteristicsofINa,current-voltage
curves were corrected for differences in driving force and
normalized to maximum peak current. Steady-state activation and
inactivation curves were fit using the Boltzmann equation I/
Imax=A/{1.0+exp[(V1/22V)/k]} to determine V1/2 (membrane
potential for the half-maximal (in)activation) and the slope factor k.
Recovery from inactivation was analyzed by fitting a double-
exponential function to the data to obtain the time constants of the
fast and the slow components of recovery from inactivation:
I/Imax=A f 6[1.02exp(2t/tf)]+As6[1.02exp(2t/ts)], where t is
therecoverytime interval,tf and tsthetime constantsofthe fast and
slow components, and Af and As the fractions of the fast and slow
components, respectively. The time course of current inactivation
was fitted by a double-exponential equation: I/Imax=A f6exp(2t/
tf)+As6exp(2t/ts), where Af and As are the fractions of the fast and
slowinactivationcomponents,andtfandtsarethetimeconstantsof
the fast and slow inactivating components, respectively.
Action potential clamp experiments. Characteristics of
SCN5A currents during an action potential upstroke were tested
using the action potential clamp technique. An action potential
waveform of a human ventricular cell was simulated using the
mathematical model by ten Tusscher, Noble, Noble and Panfilov
[45], digitized at 10 kHz, and stored as described previously in
detail [44]. The thus obtained action potential waveform was used
as command signal under voltage-clamp conditions with a cycle
length of 800 ms.
Statistics
Data are expressed as mean6SEM. Values are considered
significantly different if P,0.05 in unpaired t-test or in Two-Way
Repeated Measures of Analysis of Variance (Two-Way Repeated
Measures ANOVA) followed by pairwise comparison using the
Student-Newman-Keuls test.
Results
Biophysical characterization of INa in HEK cells
To characterize activation, steady-state inactivation, recovery
from inactivation and the development of slow inactivation,
biophysical properties of INa were first determined in conventional
VC experiments and then in alternating VC/CC experiments, in
HEK cells. To evaluate dV/dtmax as a tool for studying INa
Figure 2. ‘Dynamic’ INa activation in HEK cells assessed with VC (a) and alternating VC/CC (b). a, Typical example of Na
+ current (bottom)
during the upstroke phase of the ventricular action potential like waveform used as command potential in an action potential clamp experiment
(top). b, Typical membrane depolarization from 285 mV (top) in response to a superthreshold current pulse and dV/dt (bottom). c, Average phase
plane plots with current or dV/dt plotted against membrane potential. Note the similarity between the currrent densities of the VC and alternating
VC/CC experiments. d, Average dynamic INa activation. Solid lines represent the Boltzmann fits to the average data.
doi:10.1371/journal.pone.0015772.g002
Action Potential Upstroke and Sodium Current
PLoS ONE | www.plosone.org 4 December 2010 | Volume 5 | Issue 12 | e15772characteristics under close-to-physiological conditions, results of
VC and VC/CC experiments were compared.
Current density and voltage-dependence of activa-
tion. Figure 1 (top) shows representative INa activated by 50-
ms depolarizing voltage clamp steps of 5 mV increment in a HEK
cell using conventional VC. Typical for heterologously expressed
SCN5A current measured with square form VC steps, current
starts to activate around 260 mV, peaks around 230 mV, and
subsequently decreases in amplitude due to the reduction in Na
+
driving force (Fig. 1b). Figure 1c shows averaged data for the
voltage-dependence of ‘steady-state’ activation. Compared to the
VC configuration, where INa characteristics are measured at fixed
membrane potentials, in alternating VC/CC experiments the
conditioning membrane potential is kept at a fixed (predeter-
mined) value before the recording configuration is switched to the
CC recording configuration. Following this switch, activation of
INa will result in an ‘all-or-none’ response, and consequently the
cell will depolarize fast to approximately the reversal potential of
Na
+ current [46]. Figure 1d shows the membrane potential in the
VC/CC recording configuration in response to a super- and
subthreshold current pulse (top) and the first derivative of the
membrane potential signal (dV/dt, bottom). Remarkably, the
upstrokes in HEK cells are qualitatively similar to AP upstrokes
recorded in myocytes.
Although ‘steady-state’ Na
+ channel activation in alternating
VC/CC experiments cannot be determined, AP upstrokes can be
used to derive ‘dynamic’ activation properties of INa. To construct
dynamic INa activation properties, phase plane plots (where
current density or, equivalently, dV/dt is plotted against
membrane potential [47]) are corrected for changes in driving
force, current amplitudes normalized to the maximum peak
current, and data fitted to a Boltzmann curve to determine
membrane potential for half-maximal activation, V1/2, and the
slope factor, k. In Figure 2 and Table 1, we compare dynamic INa
activation properties measured using AP clamp experiments in the
VC mode of the patch clamp amplifier (Fig. 2a) with those of
alternating VC/CC experiments (Fig. 2b). Figure 2a shows INa
(bottom) during the upstroke (top) of an action potential clamp
experiment. Figure 2b shows dV/dt (bottom) during the upstroke
(top) of an alternating VC/CC experiment. Figure 2c shows
average phase plane plots. In both VC and alternating VC/CC
experiments, INa activates around 260 mV, peaks around 0 mV
and subsequently decreases due to reduced Na
+ driving force
(Fig. 2c). In addition, Figure 2c shows that the current densities did
not differ significantly between the VC and alternating VC/CC
experiments. The average voltage-dependence of dynamic Na
+
channel activation in VC and VC/CC experiments is shown in
Figure 2d. The dynamic activation properties of INa measured
during VC experiments are almost indistinguishable from those
measured during alternating VC/CC experiments, except for a
statistically significant difference in the slope factor k (Table 1),
indicating that the dynamic INa activation curve is steeper in VC/
CC experiments (cf. Fig. 2d).
Voltage-dependence of inactivation. The voltage
dependence of inactivation was measured using a two-pulse
protocol, where a 1-s conditioning prepulse (P1) to membrane
potentials between 2140 and 0 mV, to induce steady-state
inactivation, was followed by a 20-ms test pulse (P2) (Fig. 3, a
and b, top). The bottom panels of Figs. 3a and 3b show typical P2
currents recorded in VC mode and dV/dt values measured in
VC/CC mode, respectively. Both peak P2 currents and dV/dt
amplitudes were normalized to their maximum values and plotted
versus the conditioning pulse (P1) voltage. The thus obtained
curves were fitted with a Boltzmann distribution function y=A/
[1+exp((V1/22V)/k)] to determine the half-maximal inactivation
voltage V1/2 (membrane potential at which 50% of Na
+ channels
have entered an inactivated state) and slope factor k of voltage-
dependent inactivation. The average data on voltage-dependence
of inactivation for VC and VC/CC experiments are shown in
Figure 3c and Table 1. The inactivation properties of Na
+
channels measured during VC experiments were indistinguishable
from those measured during VC/CC experiments (Fig. 3c,
Table 1).
Recovery from inactivation. Recovery from inactivation
was measured using a two-pulse protocol, where a 1-s conditioning
prepulse (P1) to 220 mV (to inactivate Na
+ channels) was followed
by a test pulse (P2) after a variable recovery interval ranging
between 1 and 1000 ms at a recovery potential of 285 mV
(Figs. 4a and 4b, top). Figures 4a and 4b (bottom), show typical P1
and P2 currents and dV/dt values, respectively, at an interpulse
interval of 5 ms. The peak amplitudes in response to P2 were
normalized to the peak amplitudes at P1 and plotted versus the
interpulse interval. The resulting curve was fitted with a double-
exponential function to obtain the time constants and fractions of
the fast and the slow components of recovery from inactivation.
Both time constants and fractions of recovery from inactivation
were not significantly different in VC and VC/CC experiments
(Fig. 4c and Table 1).
Slow inactivation. Slow inactivation was measured using a
two-pulse protocol, where a conditioning prepulse to 220 mV (P1)
Table 1. Biophysical properties of INa at close-to-
physiological conditions determined in the VC and VC/CC
configurations in HEK cells and in rabbit ventricular myocytes.
HEK cells Cardiac myocytes
VC VC/CC VC VC/CC
Peak Na
+ current
(pA/pF)
2264634
(n=5)
2244624
(n=5)
2438627
(n=9)
2394631
(n=8)
Dynamic activation:
V1/2 (mV) 20.163.6 1.464.8 5.662.8 1.662.8
k (mV) 12.460.5 9.461.0* 13.862.8 14.562.8
(n=5) (n=5) (n=9) (n=8)
Inactivation:
V1/2 (mV) 284.962.2 284.761.4 274.960.8 274.761.5
k (mV) 25.060.1 25.260.5 24.460.2 24.460.2
(n=13) (n=8) (n=17) (n=12)
Recovery
from inactivation:
tf (ms) 6.760.7 8.961.9 9.662.3 9.960.8
ts (ms) 204651 172664 131640 99627
As/(As+Af) 0.2460.05 0.2860.05 0.1860.05 0.2160.02
(n=7) (n=7) (n=8) (n=10)
Slow inactivation
1-Peak
INa (P2/P1)
0.2260.03
(n=8)
0.2160.01
(n=7)
0.1160.02
(n=14)
0.1160.02
(n=7)
Mean6SEM, ‘n’ indicates number of cells measured. V1/2, membrane potential
for half-maximal (in)activation; k, slope factor of steady-state (in)activation
curve; tf and ts, fast and slow time constant of recovery from inactivation,
respectively; Af and As, fractions of fast and slow recovery from inactivation,
respectively; 1-Peak INa (P2/P1), fraction of channels that entered into slow
inactivation with a P1 of 1 s;
*P,0.05 for CC versus VC/CC in unpaired t-test.
doi:10.1371/journal.pone.0015772.t001
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followed by a test pulse (P2) after a 30-ms step to 285 mV to
allow the channels to recover from fast inactivation (Fig. 5, a and
b, top). Figures 5a and 5b, bottom, show typical P1 and P2
currents and dV/dt values, respectively, with a P1 duration of
1000 ms. The peak amplitudes in response to P2 were normalized
to the peak amplitudes at P1, plotted versus the duration of P1,
and designated peak INa (P2/P1). Consequently, the fraction that
entered slow inactivation equals 1 – P2/P1. The amount of Na
+
channels that entered slow inactivation was similar in VC and
VC/CC experiments (Fig. 5c and Table 1).
Properties of INa at close-to-physiological conditions in
cardiac myocytes
In the experiments above, we found that the biophysical
properties of INa in HEK cells under close-to-physiological
conditions were nearly identical in VC and alternating VC/CC
experiments. These results demonstrate that the alternating VC/
CC technique is a suitable method for determining INa properties
under close-to-physiological conditions. To demonstrate the
applicability of the technique with freshly isolated cardiac
myocytes, we used the VC/CC approach to characterize INa in
rabbit left ventricular myocytes isolated from healthy animals
(Ctrl) and from those with heart failure (HF).
Figure 6 shows typical AP upstrokes (panel a), their phase plane
plots (panel b), dynamic activation (panel c), inactivation (panel d),
recovery from inactivation (panel e) and slow inactivation
characteristics (panel f) in Ctrl and HF myocytes, whereas
Table 1 summarizes the average biophysical parameters of INa
in Ctrl and HF myocytes. The dV/dt amplitudes did not differ
significantly between Ctrl and HF (Fig. 6b) and the voltage
dependence of dynamic activation was similar in both groups
(Fig. 6c). Moreover, voltage dependence of inactivation as well as
recovery from inactivation was similar in Ctrl and HF myocytes.
Finally, slow inactivation did not differ significantly between Ctrl
and HF. Despite the clearly developed heart failure of our animal
model, none of the biophysical properties of INa differed between
Ctrl and HF myocytes under close-to-physiological conditions.
Due to the close-to-physiological temperature and ion concentra-
tions, and to the absence of specific ion channel blockers, we cannot
exclude interference of other ion currents, specifically the transient
outward K
+ current (Ito1)a n dt h eL - t y p eC a
2+ current (ICa,L), during
the dV/dtmax measurements in cardiac myocytes of Fig. 6.
Therefore, we studied the effects of the ICa,L blocker nifedipine
Figure 3. Voltage-dependence of INa inactivation in HEK cells assessed with VC (a) and alternating VC/CC (b). a and b, Top: voltage
clamp (a) and VC/CC (b) protocols. Bottom: typical currents (a) and dV/dt’s (b) measured after a 1-s prepulse (P1) to membrane potentials between
2110 and 265 mV. c, Average voltage-dependence of inactivation. Solid lines represent the Boltzmann fits to the average data.
doi:10.1371/journal.pone.0015772.g003
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on dV/dtmax. Neither nifedipine (399610 (nifedipine) vs. 39567
V/s (control), n=5) nor 4-aminopyridine (399631 (4-aminopyr-
idine) vs. 401627 V/s (control), n=6) affected dV/dtmax.
Discussion
In cardiac myocytes, reliable VC measurements of INa at close-
to-physiological conditions are virtually impossible due to the large
amplitude and rapidly activating nature of INa, which seriously
hamper the quality of voltage control over the membrane. With
the increasing need for accurate measurements of the biophysical
properties of INa under close-to-physiological conditions in cardiac
myocytes, we therefore sought for a relatively simple technique
that would allow the acquisition of such data, which we found in
the alternating VC/CC technique. In this technique, there are no
problems with voltage control, because dV/dtmax, which is
proportional to the Na
+ ion current, is acquired during the CC
period. Yet, cells are clamped with protocols similar to those used
in conventional VC experiments, allowing acquisition of biophys-
ical parameters as in conventional VC.
In this paper we describe the use of alternating VC/CC
experiments for investigating biophysical properties of INa under
close-to-physiological conditions in detail. In HEK cells heterol-
ogously expressing SCN5A current, the conventional VC and the
alternating VC/CC experiments resulted in similar SCN5A
current characteristics, thus validating the alternating VC/CC
technique as an alternative to conventional VC for determining
biophysical properties of INa. Moreover, we demonstrate that the
alternating VC/CC technique is a suitable method for determin-
ing INa properties under close-to-physiological conditions in
cardiac myocytes.
dV/dtmax as a tool in studying Na
+ channel properties
In the past, dV/dtmax during an action potential upstroke was
used to determine: i) INa density [48]; ii) INa activation properties
(resulting from plotting dV/dt versus the membrane potential in
phase-plane plots [46]); iii) INa inactivation properties, also called
membrane ‘‘responsiveness’’ [31,49–51]; iv) recovery from INa
inactivation properties [52,53]; and v) development of slow
inactivation of INa [33]. Even though the use of dV/dtmax as an
index of INa provided us with important information on Na
+
channel behaviour, dV/dtmax has often been regarded as a
nonlinear representation of the underlying Na
+ channel activity
[34,37,54]. This argument and the refinement of the VC technique,
Figure 4. Recovery from INa inactivation in HEK cells assessed with VC (a) and alternating VC/CC (b). a and b, Top: voltage clamp (a) and
VC/CC (b) protocols with an interpulse interval of 1–1000 ms, as indicated. Bottom: typical examples of recovery from inactivation with an interpulse
interval of 5 ms. c, Average recovery from inactivation. Inset, Average recovery from inactivation on a logarithmic time scale. Solid lines are double-
exponential fits to the average data.
doi:10.1371/journal.pone.0015772.g004
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INa. However, with the need for reliable INa measurements at both
physiological temperature and physiological Na
+ gradients in
cardiac myocytes, the method was recently reintroduced [55,56].
Previous VC experiments performed in HEK cells demonstrat-
ed that heterologously expressed SCN5A currents can reliably be
characterized under close-to-physiological conditions [11–17]. In
the present study we show that SCN5A current properties
determined from the analysis of dV/dtmax (VC/CC) and those
determined in conventional VC closely match (Figures 1, 2, 3, 4, 5,
Table 1). This finding is in line with results of Hondeghem and
coworkers [25,33,35,57], but contrasts findings of Tsien, Sheets,
and their coworkers [18,20,37,54], which support the nonlinear
relationship between dV/dtmax and the underlying INa. It should,
however, be noted that the nonlinearity between INa and dV/
dtmax becomes smaller at higher temperatures [37]. While the
studies of Tsien and coworkers were - for methodological reasons -
executed at low temperatures [18,20,37,54], we were able to
perform our experiments at 36uC. This may explain why we did
not observe indications for a nonlinear relationship, if any,
between dV/dtmax and the underlying INa.
Although SCN5A current properties determined from the
analysis of dV/dtmax (VC/CC) and those determined in
conventional VC closely match (Figures 1, 2, 3, 4, 5, Table 1),
we found a tendency of smaller peak Na
+ current in VC/CC
compared to VC experiments (cf. Table 1). Although the
differences did not reach statistical significance, the smaller peak
current may be due to some channels going into an inactivated
state during the CC period of the VC/CC technique. Further-
more, we found a significantly steeper dynamic INa activation
curve in our VC/CC experiments (cf. Fig. 2d, Table 1). This
might be due to passive membrane loading in the CC period of the
VC/CC technique, which suppresses the early phase of dynamic
activation. This process does not affect the dV/dtmax and therefore
does not influence the analyzed biophysical properties.
Na
+ current properties in Ctrl and HF myocytes under
close-to-physiological conditions
The reported effects of HF on cardiac Na
+ current character-
istics are not consistent (see Ref. [29], and primary refs cited
therein). The discrepancies between the various studies may be
due to differences in the methods used to induce HF, in species, or
Figure 5. Slow inactivation properties in HEK cells assessed with VC (A) and alternating VC/CC (B). a and b, Top: voltage clamp (A) and
VC/CC (B) protocols, with a conditioning prepulse interval (P1) of 10–1000 ms, as indicated, and a 30-ms interval to remove fast inactivation. Bottom:
typical examples of slow inactivation with a conditioning prepulse of 1000 ms. c, Average development of slow inactivation. Note the logarithmic
time scale. Solid lines are double-exponential fits to the average data.
doi:10.1371/journal.pone.0015772.g005
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properties in Ctrl and HF myocytes using the alternating VC/CC
technique to demonstrate its usefulness for INa characterization
under close-to-physiological conditions in cardiac myocytes.
Below, we compare our findings with those from other studies
with rabbit HF models.
Using a well-characterized rabbit model of pressure and volume
overload-induced HF, we found that all analyzed biophysical
properties of INa were similar in Ctrl and HF myocytes. This
agrees with results of conventional VC obtained at room
temperature in the same model of HF [55,58,59]. Although this
pressure and volume overload rabbit model HF is not associated
with a ‘persistent’, ‘late’ or ‘sustained’ INa [58], the VC/CC
technique is not suitable for characterization of sustained INa.
However, the relatively slow and small sustained INa can be
measured accurately in cardiac myocytes as tetrodotoxin-sensitive
current in conventional VC under close-to-physiological condi-
tions [26].
Using HEK cells as an expression system that allows a direct
comparison to data from conventional VC, we have shown that
biophysical properties of INa, including current density, voltage
dependent (in)activation, development of inactivation, and recov-
ery from inactivation, can be accurately determined through
alternating VC/CC experiments under close-to-physiological
conditions. Thus, our study demonstrates that the alternating
VC/CC technique is a valuable experimental tool for INa
measurements in cardiac myocytes under close-to-physiological
conditions.
Technical considerations
In the present study, we used a custom-made patch clamp
amplifier to perform the alternating VC/CC technique. Nowa-
days, sophisticated commercially available patch clamp amplifiers
also exhibit the possibility to make a computer-controlled rapid
switch between recording modes (VC or CC), thus allowing a
straightforward implementation of the VC/CC technique. These
include widely used amplifiers from major manufacturers, such as
the MultiClamp 700B from Molecular Devices (Sunnyvale, CA,
USA), the RK-400 from Bio-Logic (Claix, France), the VE-2
Whole-Cell Patch Clamp Amplifier from Alembic Instruments
(Montreal, Quebec, Canada), and the EPC 10 USB Patch Clamp
Amplifier family from HEKA (Lambrecht/Pfalz, Germany).
Limitations
While the alternating VC/CC technique is an appropriate
method to characterize INa density and gating properties, it does
not allow the estimation of late or persistent INa. However, as set
out above, this sustained INa can be measured accurately in
cardiac myocytes as tetrodotoxin-sensitive current in conventional
VC under close-to-physiological conditions. Furthermore, due to
the close-to-physiological temperature and ion concentrations, and
to the absence of specific ion channel blockers, we cannot exclude
interference of other ion currents, specifically the transient
outward K
+ current (Ito1) and the L-type Ca
2+ current (ICa,L),
during the dV/dtmax measurements in cardiac myocytes. Howev-
er, it may be argued that the contribution of Ito1 and ICa,L to the
cardiac action potential upstroke is limited for several reasons.
Figure 6. INa properties in control (CTRL) and heart failure (HF) rabbit ventricular myocytes assessed with alternating VC/CC, using
the protocols shown in Figs. 1–5. a, Typical examples of AP upstrokes (top) and their dV/dt’s (bottom). b, Current-voltage relationships of the AP
upstrokes. c, Dynamic INa activation curve with Boltzmann fits in solid lines. d, Steady-state voltage-dependence of inactivation with Boltzmann fits in
solid lines. e, Recovery from inactivation with double-exponential fits in solid lines. f, Development of slow inactivation with double-exponential fits
in solid lines.
doi:10.1371/journal.pone.0015772.g006
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+ channels in myocytes has a relatively
high density compared to other channels; in our hands, average
dV/dtmax in rabbit ventricular myocytes was around 400 V/s
(Fig. 6b), which corresponds to a 400 pA/pF current. Second,
action potential upstrokes in ventricular myocytes are extremely
fast, with an upstroke duration of approximately 0.5 ms (Fig. 6a), a
time window during which Ito1 and ICa,L exhibit negligible
activation. In line with these arguments, we found no significant
effects of the Ito1 blocker 4-aminopyridine and the ICa,L blocker
nifedipine on the dV/dtmax in cardiac myocytes.
Conclusions
The behaviour of Na
+ channels in cell expression systems differs
from that in cardiac myocytes. Therefore, the need for accurate
INa measurements under close-to-physiological conditions in
myocytes of healthy animals and in myocytes of animal models
with various cardiac disorders is increasing. Changes in gating
properties of Na
+ channels due to mutations may be more
prominent at near-physiological temperature than at room
temperature. Our study demonstrates that the alternating VC/
CC technique facilitates successful analysis of Na
+ channel
properties in cardiac cells under close-to-physiological conditions.
In addition, the analysis of dV/dt immediately unravels the
physiological consequences of altered Na
+ channel properties.
Overall, due to its simplicity and convenience, the alternating VC/
CC technique is a valuable experimental tool in cardiac cellular
electrophysiology.
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